Tissue Plasminogen Activator Market Size, Share, Trend, Outlook, Future Growth Analysis And Synthesis 2018 - 2026 Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration. tPA is also be produced by using recombinant technology techniques known as recombinant tissue plasminogen activator (rtPA). Specific rtPAs are tenecteplase, alteplase, and reteplase. These enzymes are used in clinical treatment of thrombotic stroke or embolic stroke. tPA is a drug that dissolves blood clots. It is a thrombolytic agent which can be administrated into the veins. Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2469 Global Tissue Plasminogen Activator Market: Drivers Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke. Increasing incidences of stroke has boosted the tissue plasminogen activator market size. According to John Hopkins Medicines (JHM) in the U.S., around 795,000 people in the U.S. suffer from stroke per year, as reported in 2014. According to the World Health Organization (WHO), stroke is the second leading cause of death and the third leading cause of disability, worldwide, as reported in 2012. This is one of the major factors driving the tissue plasminogen activator market growth. Global Tissue Plasminogen Activator Market: Regional Analysis North America is the leader in the global tissue plasminogen activator market, owing to rising awareness about stroke and huge spending on treatment of stroke. For instance, in 2017, the American Heart Association (AHA) recorded stroke costs as US$ 34 billion in the U.S. every year, which includes medicines for the treatment of stroke and cost of health care services. Asia pacific is the fastest growing region in the tissue plasminogen activator market, owing to increasing demand drug coupled with rising stroke incidences in the region. According to WHO, Indonesia, Philippines, China, and India have highest rates of stroke, which is 186.3, 134.7, 128, and 71.5, respectively, as recorded in 2017. Report includes chapters which deeply display the following deliverable about industry : • Tissue Plasminogen Activator Market Research Objective and Assumption • Tissue Plasminogen Activator Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Tissue Plasminogen Activator Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Tissue Plasminogen Activator Market, By Regions • Tissue Plasminogen Activator Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Tissue Plasminogen Activator Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Tissue Plasminogen Activator Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Tissue Plasminogen Activator Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Global Tissue Plasminogen Activator Market: Competitive Landscape Key players operating in the global tissue plasminogen activator market include Bayer AG, Abcam, Calbiochem, Merck & Company, Roche, Sekisui Diagnostics, Genentech, Sigma-Aldrich, Taj Pharmaceuticals, and Cadila Healthcare Ltd. Global Tissue Plasminogen Activator Market: Taxonomy The global tissue plasminogen activator market is segmented on the basis of dosage, route of administration, application, and region. By Route of administration: • Intravenous • Regional intra-arterial By Application: • Blood clots • Pulmonary embolism • Myocardial infarction • Stroke For More Information, Browse Complete Report Here: https://www.coherentmarketinsights.com/ongoing-insight/tissue-plasminogen-activator-market2469 About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200, Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Increasing prevalence of stroke incidences in growing geriatric population is another major factor driving the market size.
© Copyright 2024 Paperzz
